CSPC Pharma Acquires 5.50 Million Shares On-Market for 2026 Restricted Share Award Scheme

Bulletin Express06-08

On 8 June 2026, CSPC Pharma executed an on-market repurchase of 5.50 million shares under its 2026 Restricted Share Award Scheme. The shares were bought at an average price of HK$7.0718, bringing the cash outlay to approximately HK$38.90 million and representing about 0.05 % of the company’s total issued share capital.

Following the transaction, the scheme’s trustee now holds 19.30 million shares, equivalent to roughly 0.17 % of CSPC Pharma’s shares outstanding.

Separately, BOCI-Prudential Trustee Limited, trustee of the 2018 Share Award Scheme, continues to hold 117.00 million shares on trust for that plan.

The board stated it will periodically determine additional awards and any further on-market purchases for both the 2018 and 2026 share award schemes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1134921602?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-08 20:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1134921602","market":"us","top_or_hot":-1,"title":"CSPC Pharma Acquires 5.50 Million Shares On-Market for 2026 Restricted Share Award Scheme","media":"Bulletin Express","content":"<p>On 8 June 2026, CSPC Pharma executed an on-market repurchase of 5.50 million shares under its 2026 Restricted Share Award Scheme. The shares were bought at an average price of HK$7.0718, bringing the cash outlay to approximately HK$38.90 million and representing about 0.05 % of the company’s total issued share capital.</p>\n<p>Following the transaction, the scheme’s trustee now holds 19.30 million shares, equivalent to roughly 0.17 % of CSPC Pharma’s shares outstanding.</p>\n<p>Separately, BOCI-Prudential Trustee Limited, trustee of the 2018 Share Award Scheme, continues to hold 117.00 million shares on trust for that plan.</p>\n<p>The board stated it will periodically determine additional awards and any further on-market purchases for both the 2018 and 2026 share award schemes.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CSPC Pharma Acquires 5.50 Million Shares On-Market for 2026 Restricted Share Award Scheme</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCSPC Pharma Acquires 5.50 Million Shares On-Market for 2026 Restricted Share Award Scheme\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-08 20:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 8 June 2026, CSPC Pharma executed an on-market repurchase of 5.50 million shares under its 2026 Restricted Share Award Scheme. The shares were bought at an average price of HK$7.0718, bringing the cash outlay to approximately HK$38.90 million and representing about 0.05 % of the company’s total issued share capital.</p>\n<p>Following the transaction, the scheme’s trustee now holds 19.30 million shares, equivalent to roughly 0.17 % of CSPC Pharma’s shares outstanding.</p>\n<p>Separately, BOCI-Prudential Trustee Limited, trustee of the 2018 Share Award Scheme, continues to hold 117.00 million shares on trust for that plan.</p>\n<p>The board stated it will periodically determine additional awards and any further on-market purchases for both the 2018 and 2026 share award schemes.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01093","symbol_name":"石药集团","start_time":0,"source_url":"","article_id":"1134921602","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1134921602","pubTimestamp":1780921374,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 8 June 2026, CSPC Pharma executed an on-market repurchase of 5.50 million shares under its 2026 Restricted Share Award Scheme. The shares were bought at an average price of HK$7.0718, bringing the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01093":"石药集团"},"translate_title":"石药集团为2026年限制性股票奖励计划在市场上收购550万股股票","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01093":1},"content_text":"On 8 June 2026, CSPC Pharma executed an on-market repurchase of 5.50 million shares under its 2026 Restricted Share Award Scheme. The shares were bought at an average price of HK$7.0718, bringing the cash outlay to approximately HK$38.90 million and representing about 0.05 % of the company’s total issued share capital.\nFollowing the transaction, the scheme’s trustee now holds 19.30 million shares, equivalent to roughly 0.17 % of CSPC Pharma’s shares outstanding.\nSeparately, BOCI-Prudential Trustee Limited, trustee of the 2018 Share Award Scheme, continues to hold 117.00 million shares on trust for that plan.\nThe board stated it will periodically determine additional awards and any further on-market purchases for both the 2018 and 2026 share award schemes.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1134921602","isCrawlerRequest":true}